Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
XLY.TOthis companyAuxly Cannabis Group Inc.	CA$3.55	4.6×	1.09×	1.27×	4.33×	-243.0%	57.3%	21.6%	27.6%	23.6%	13.9%	12.1%	0.32×	0.5×	5.15×	2.2×	0.0%	6	1.45	4	A-
CRDL.TOCardiol Therapeutics Inc.	CA$1.44	-3.36×	6.37×	0×	-2.71×	-83.2%	0.0%	0.0%	0.0%	-189.2%	-190.6%	-21.0%	0.01×	0.62×	0×	4.16×	0.0%	2	5.98	2	C
CRRX.TOCareRx Corporation	CA$3.11	9.1×	2.19×	0.65×	10.63×	374.7%	25.0%	3.2%	7.1%	23.9%	6.0%	9.2%	0.71×	2.23×	1.74×	1.06×	0.5%	5	1.17	4	A
CYBN.NECybin Inc.	CA$12.78	-1.59×	1.01×	0×	-0.54×	-62.3%	0.0%	0.0%	0.0%	-63.2%	-60.9%	-57.1%	0×	1.11×	-48.88×	9.52×	0.0%	3	8.63	2	C
DB.VDecibel Cannabis Company Inc.	CA$1.98	-21.57×	1.02×	0.56×	-9.27×	-169.4%	15.5%	-15.4%	-2.6%	-4.7%	-16.2%	8.6%	0.71×	-3.39×	-6.57×	1.34×	0.0%	2	1.5	1	C-
HLS.TOHLS Therapeutics Inc.	CA$4.41	-8.77×	1.8×	1.96×	8.25×	26.6%	42.5%	-7.4%	-22.4%	-20.5%	-3.5%	14.3%	0.81×	2.11×	-0.58×	1.11×	0.0%	5	-1.12	2	C+
Peer median	—	-3.36×	1.8×	0.56×	-0.54×	-62.3%	15.5%	0.0%	0.0%	-20.5%	-16.2%	8.6%	0.71×	1.11×	-0.58×	1.34×	0.0%	3	1.5	2	—